Dismiss Modal

Safi Mohammed, DO

Riverside Healthcare Urologist, Safi Mohammed, DO recently became one of the first ten in the country to trial new technology to help men who suffer from BPH (benign prostatic hyperplasia) commonly known as prostate enlargement.
Dr. Mohammad was selected to be part of the trial because of his success with patient outcomes and volumes. He is one of three physicians in Illinois and ten in the country to pioneer the trial.
“Urolift is a revolutionary solution for men living with BPH. I’m proud to be selected help develop new technology to better benefit patients,” said Dr. Mohammed.
The procedure is a one-time, minimally invasive solution that provides rapid relief and recovery for men living with symptoms of an enlarged prostate. It is designed to end the need for medications designed to treat BPH. UroLift works by lifting and holding the enlarged prostate tissue so it no longer blocks the urethra, impeding urination and other issues. It is the only BPH treatment that does not require heating, cutting, or removal of the prostate tissue.
Patients who receive the procedure with technology developed by Urolift typically return home the same day and fully recover within a few days rather than weeks or months with other treatments.

A Common Concern

The prostate is a walnut-sized gland in men that surrounds the urethra (the passageway that drains urine from the body). An enlarged prostate presses on and blocks the urethra, which can cause bothersome urinary symptoms.

Additionally, an enlarged prostate can cause sleep issues which can lead to a loss in productivity, depression and an overall decreased quality of life.

This condition is a common and affects over 40 million men in the United States. Over 40 percent of men in their 50s experience enlarged prostates and that number jumps to 80 percent by the time men are in their 70s.

Most men living with enlarged prostate symptoms take prescription medications after they’re diagnosed. Often the prescriptions don’t provide adequate relief and may cause dizziness, fatigue, and sexual dysfunction.

About Safi Mohammed, DO

As a urologist, Dr. Mohammed diagnoses and treats diseases of the urinary tract in both men and women. Additionally, he treats anything involving men’s reproductive health.
Dr. Mohammed joined Riverside Urology Specialist in 2019. He completed his Doctor of Osteopathic Medicine at Midwestern University: Chicago College of Osteopathic Medicine in Downers Grove, IL. He then went onto complete a Surgery Internship at McLaren Macomb Hospital in Mt. Clemens, MI. Dr. Mohammed added to his experience through a Urological Surgery Residency, which he completed at Michigan State University: Beaumont, Henry Ford and McLaren Macomb Hospitals in Detroit, MI.
In addition to his education, Dr. Mohammed is a member of the American Urological Association, the American College of Osteopathic Surgeons and the American Osteopathic Association. He is also certified in minimally invasive laparoscopic and robotic surgery. Dr. Mohammed has a continuing passion for using the latest technology to help improve patients’ lives.
“Growing up, I was raised to try to help people. Helping people recover their health is something that is near and dear to my heart,” commented Dr Mohammed.
“As a urologist, because of the breadth of material I see, I try to keep a good sense of humor and rapport with my patients.
To make an appointment with Dr. Mohammed or find out more about Urolift, please call (815) 934-2122.
Related Articles
Read article
True Leading-Edge Spine Surgery Takes Place at Riverside Medical Center

12/14/2017 ...

Read article
Riverside Hosts Open House for New Pediatric Therapy Program

KANKAKEE, IL (November 9, 2018) - Riverside Healthcare...

Read article
Riverside Receives Donation of Homeless Care Kits

Riverside Healthcare accepted a cart full of homeless care kits from the local Bradley Target team to help patients in need.

Read article
COVID-19 Testing for Bourbonnais and Manteno Residents

Riverside Healthcare will be providing COVID-19 testing to Village of Bourbonnais and Village of Manteno on Monday, May 18.